Journal
VACCINE
Volume 35, Issue 15, Pages 1898-1906Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2017.02.038
Keywords
Cryopreservation; Malaria; TRAP; CSP; ChAd63; MVA; PBMC
Categories
Funding
- PATH
- University of Oxford
- PATH Malaria Vaccine Initiative
- United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre [A91301]
- Wellcome Trust [084113/Z/07/Z, 45488/Z/05]
- National Institute for Health Research [NF-SI-0509-10233, NF-SI-0514-10158] Funding Source: researchfish
- Wellcome Trust [104750/Z/14/Z] Funding Source: researchfish
Ask authors/readers for more resources
Ex vivo functional immunoassays such as ELISpot and intracellular cytokine staining (ICS) by flow cytometry are crucial tools in vaccine development both in the identification of novel immunogenic targets and in the immunological assessment of samples from clinical trials. Cryopreservation and subsequent thawing of PBMCs via validated processes has become a mainstay of clinical trials due to processing restrictions inherent in the disparate location and capacity of trial centres, and also in the need to standardize biological assays at central testing facilities. Logistical and financial requirement to batch process samples from multiple study timepoints are also key. We used ELISpot and ICS assays to assess antigen-specific immunogenicity in blood samples taken from subjects enrolled in a phase II malaria heterologous prime-boost vaccine trial and showed that the freeze thaw process can result in a 3-5-fold reduction of malaria antigen -specific IFN gamma-producing CD3(+)CD4(+) effector populations from PBMC samples taken post vaccination. We have also demonstrated that peptide responsive CD8(+) T cells are relatively unaffected, as well as CD4(+) T cell populations that do not produce IFN gamma. These findings contribute to a growing body of data that could be consolidated and synthesised as guidelines for clinical trials with the aim of increasing the efficiency of vaccine development pipelines. (C) 2017 The Authors. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available